Date: 2008-09-18 21:30:47Immune system Medicine Regeneron Monoclonal antibodies Astellas Pharma Biopharmaceutical Polyclonal antibodies Monoclonal antibody therapy George Yancopoulos Biotechnology Immunology Biology | | ASTELLAS LICENSES REGENERON’S VELOCIMMUNE® TECHNOLOGY FOR DISCOVERING HUMAN MONOCLONAL ANTIBODIES Tokyo, Japan and Tarrytown, NY – (March 30, 2007) – Astellas Pharma Inc. (“Astellas”; Headquarters: Tokyo, JapaAdd to Reading ListSource URL: www.astellas.comDownload Document from Source Website File Size: 21,76 KBShare Document on Facebook
|